Cabazitaxel EVER Pharma

Medicinal product

(Invented) name

Cabazitaxel EVER Pharma

Active substance (s)

Kabazitakselis

Strength

10 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01CD04, Cabazitaxel

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-02-07

Date of renewal

Documents

2364_Cabazitaxel EVER Pharma 10mg-ml_konc_inf_tirp_PL_2025-02-07.docx

2364_Cabazitaxel EVER Pharma 10mg-ml_konc_inf_tirp_PZ_2025-02-07.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml tirpalo yra:	1 ml
Kabazitakselis	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116600	102699	1102699	flakonas	6 ml N1		Receptinis	LT/L/25/2364/001	Netiekiama	-	2025-08-11	Yes	2025-07-03	2025-10-15	Download

Stadijos

Data	Stadija
2025-02-07	Registruotas